Citations

Clear

22 citation(s) found for "Chen, Junjie".

Sustained mTORC1 activation in activated T cells impairs vaccine responses in older individuals
Lin, Xiaorong , Du, Yanhua , Kan, Shuo , Chen, Junjie , Yin, Yunxue, Li, Linlin , Jiang, Wuhua , Cao, Wenqiang , Kim, Chulwoo , Chen, Liang , Wang, Shiwen , Goronzy, Jörg J. , Jin, Jun , Jiang, Wenrong , Cao, Wenqiang , Kim, Chulwoo , Chen, Liang , Wang, Shiwen , Jin, Jun , Goronzy, Jorg , Lin, Xiaorong , Du, Yanhua , Li, Linlin, Chen, Jingwen, Chen, Jingwen

Mayo Clinic

Science Advances | April 18, 2025 | Volume: 11 | Issue: 16 | Pages: No page available

10.1126/sciadv.adt4881 | PMID 40249803 Get It

T cell aging contributes to the lower vaccine efficacy in older adults, yet the molecular mechanism remains elusive. Here, we show the density of initially responding naïve CD4 + T cells is instructive in T follicular helper (TFH) cell fate decisions and declines with age. A lower number of initially responding cells did not affect TFH differentiation at peak responses after immunization but accounted for an increased contraction phase manifesting as a larger loss of CXCR5 expression. Mechanistically, cells activated at a lower initial density had more sustained mammalian target of rapamycin complex 1 (mTORC1) activities that impair CXCR5 maintenance. YAP-dependent regulation of SLC7A5 involved in the cell density–dependent regulation of mTORC1 activities and TFH loss. Old mice fed with a leucine-restricted diet after peak responses showed smaller TFH loss and improved humoral immune responses. Attenuating mTORC1 signaling after peak response is a strategy to boost vaccine responses in older individuals.
Recent Developments in Glioblastoma‐On‐A‐Chip for Advanced Drug Screening Applications
Maity, Surjendu , Bhuyan, Tamanna , Kawakita, Satoru , Sharma, Saurabh , Nguyen, Huu Tuan , Najafabadi, Alireza Hassani , Chen, Junjie , Yilgor, Can , Choroomi, Auveen, Torres, Emily, Mecwan, Marvin , Wang, Zhaohui , Quiñones‐Hinojosa, Alfredo , Jucaud, Vadim , Dokmeci, Mehmet R. , Kawakita, Satoru , Sharma, Saurabh , Nguyen, Huu Tuan , Hassani Najafabadi, Alireza , Khorsandi, Danial , Yilgor, Can , Moniz-Garcia, Diogo, Jucaud, Vadim , Dokmeci, Mehmet Remzi , Khademhosseini, Ali , Jewell, Christopher M. , Ermis, Menekşe , Falcone, Natashya , Mandal, Kalpana , Torres, Emily, John, Johnson V. , Akbari, Mohsen , Moniz‐Garcia, Diogo , Khademhosseini, Ali

Mayo Clinic

Small | November 13, 2024 | Volume: 21 | Issue: 1 | Pages: No page available

10.1002/smll.202405511 | PMID 39535474 Get It

Abstract Glioblastoma (GBM) is an aggressive form of cancer, comprising ≈80% of malignant brain tumors. However, there are no effective treatments for GBM due to its heterogeneity and the presence of the blood‐brain barrier (BBB), which restricts the delivery of therapeutics to the brain. Despite in vitro models contributing to the understanding of GBM, conventional 2D models oversimplify the complex tumor microenvironment. Organ‐on‐a‐chip (OoC) models have emerged as promising platforms that recapitulate human tissue physiology, enabling disease modeling, drug screening, and personalized medicine. There is a sudden increase in GBM‐on‐a‐chip models that can significantly advance the knowledge of GBM etiology and revolutionize drug development by reducing animal testing and enhancing translation to the clinic. In this review, an overview of GBM‐on‐a‐chip models and their applications is reported for drug screening and discussed current challenges and potential future directions for GBM‐on‐a‐chip models.
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer
Hsieh, Cheng‐En , Krishnan, Sunil , Wu, Ren‐Chin , Boda, Akash R. , Liu, Arthur , Winkler, Michelle , Hsu, Wen‐Hao , Lin, Steven H. , Hung, Mien‐Chie , Bhanu, Krithikaa Rajkumar , Srinivasamani, Anupallavi, Azevedo, Ricardo , Chou, Yung‐Chih , DePinho, Ronald A. , Gubin, Matthew M. , Slay, Ravaen, Hegde, Shweta , Hartley, Genevieve , Lea, Spencer T. , Prasad, Rishika , Morrow, Brittany, Couillault, Coline , Steiner, Madeline , Wang, Chun‐Chieh, Venkatesulu, Bhanu Prasad , Curran, Michael A. , Hsieh, Rodney Cheng-En , Lin, Steven H , Chan, Li-Chuan , De Azevedo, Ricardo Alexandre , Chou, Yung-Chih , DePinho, Ronald A , Gubin, Matthew , Vilar, Eduardo , Chen, Chao Hsien , Jayaprakash, Priyamvada , Lea, Spencer T , Prasad, Rishika , Couillault, Coline Agnes , Wang, Chun-Chieh , Taniguchi, Cullen , Kim, Betty Y S , Chen, Junjie , Rudqvist, Nils-Petter , Curran, Michael A , Krishnan, Sunil , Liu, Arthur J , Kim, Betty Y.S. , Chen, Junjie

Mayo Clinic

Science Immunology | June 10, 2022 | Volume: 7 | Issue: 72 | Pages: No page available

10.1126/sciimmunol.abl9330 | PMID 35687697 Get It

Radiotherapy (RT) of colorectal cancer (CRC) can prime adaptive immunity against tumor-associated antigen (TAA)–expressing CRC cells systemically. However, abscopal tumor remissions are extremely rare, and the postirradiation immune escape mechanisms in CRC remain elusive. Here, we found that irradiated CRC cells used ATR-mediated DNA repair signaling pathway to up-regulate both CD47 and PD-L1, which through engagement of SIRPα and PD-1, respectively, prevented phagocytosis by antigen-presenting cells and thereby limited TAA cross-presentation and innate immune activation. This postirradiation CD47 and PD-L1 up-regulation was observed across various human solid tumor cells. Concordantly, rectal cancer patients with poor responses to neoadjuvant RT exhibited significantly elevated postirradiation CD47 levels. The combination of RT, anti-SIRPα, and anti–PD-1 reversed adaptive immune resistance and drove efficient TAA cross-presentation, resulting in robust TAA-specific CD8 T cell priming, functional activation of T effectors, and increased T cell clonality and clonal diversity. We observed significantly higher complete response rates to RT/anti-SIRPα/anti–PD-1 in both irradiated and abscopal tumors and prolonged survival in three distinct murine CRC models, including a cecal orthotopic model. The efficacy of triple combination therapy was STING dependent as knockout animals lost most benefit of adding anti-SIRPα and anti–PD-1 to RT. Despite activation across the myeloid stroma, the enhanced dendritic cell function accounts for most improvements in CD8 T cell priming. These data suggest ATR-mediated CD47 and PD-L1 up-regulation as a key mechanism restraining radiation-induced immune priming. RT combined with SIRPα and PD-1 blockade promotes robust antitumor immune priming, leading to systemic tumor regressions.
Modified Use of Costal Cartilage in Asians for the Correction of Nostril Asymmetry in Unilateral Secondary Cleft Lip Nasal Deformity
Zhang, Zhenyu , Huang, Tony Chieh‐Ting , He, Yinhai , Li, Zhengyong , Chen, Junjie , Qing, Yong , He, Yinhai, Shang, Li , Cen, Ying

Mayo Clinic

Annals of Plastic Surgery | July 30, 2020 | Volume: 86 | Issue: 2 | Pages: 175-181

10.1097/sap.0000000000002503 | PMID 32756249 Get It

Background Weak alar cartilage and lack of soft tissue on the cleft side are considered to be the main critical factors leading to the asymmetry of bilateral nostrils. The costal cartilage can provide strong structural support and can be used to maintain long-term stability of nostril shape after surgical correction. With the advancement in rhinoplasty techniques, the application and understanding of costal cartilage in cleft lip nasal deformity is still on going. Herein, we present our technique of applying costal cartilage to provide nostril support and correct asymmetry in Asian patients with unilateral secondary cleft lip nasal deformity. Methods Ninety-seven patients who underwent nostril asymmetry correction from January 1, 2013, to October 31, 2018, were analyzed retrospectively. Modified integrative alar cartilage strut and diced nostril augmentation with costal cartilage were implemented to improve the collapsed and flat cleft-side nostril. The release and restoration of muscle and bone were also performed when required. Surgical outcomes were analyzed based on the comparison of nostril parameters, the shape and contour, and symmetry of bilateral nostrils after surgery. During postoperative follow-up, the patients' satisfactions with the corrective outcomes were also investigated. Results All patients received the corrective operations with complete survival of all implanted cartilages. The nostril width was narrower in postoperative group (P < 0.05). The nostril height and long axis angle were higher postoperatively (P < 0.05). After correction, the proportion of moderate type increased from 13.4% to 80.4%, whereas the proportion of horizontal type decreased from 86.6% to 17.5%. The symmetry score on the nostril parameters manifested the rate of high score (AS >3) in postoperative groups were 84.5%, 93.8%, and 87.6% for width, height, and angle of the long axis, respectively. They were higher compared with those of preoperative group (0%). More than 95% of the patients were satisfied with the overall aesthetic outcome of the surgery. Conclusions Through ameliorating its constructive technology and optimizing its filling form, the modified use of costal cartilage displayed excellent correction effects in the width, height, and long axis angle asymmetry of Asian patients' nostril. Precise and comprehensive rhinoplasty technique is the cornerstone for achieving satisfactory long-term aesthetic outcomes, especially in severe cases, such as secondary cleft lip nasal deformity.
Displacement analysis of myocardial mechanical deformation (DIAMOND) reveals segmental susceptibility to doxorubicin-induced injury and regeneration
Chen, Junjie , Ding, Yichen , Chen, Michael , Gau, Jonathan , Jen, Nelson, Nahal, Chadi, Tu, Sally , Chen, Cynthia , Zhou, Steve , Chang, Chih-Chiang, Lyu, Jintian, Packard, René R. Sevag , Tu, Sally , Xu, Xiaolei , Hsiai, Tzung K. , Packard, Rene R S

Mayo Clinic

JCI Insight | April 17, 2019 | Volume: 4 | Issue: 8 | Pages: No page available

10.1172/jci.insight.125362 | PMID 30996130 Get It

Zebrafish are increasingly utilized to model cardiomyopathies and regeneration. Current methods evaluating cardiac function have known limitations, fail to reliably detect focal mechanics, and are not readily feasible in zebrafish. We developed a semiautomated, open-source method — displacement analysis of myocardial mechanical deformation (DIAMOND) — for quantitative assessment of 4D segmental cardiac function. We imaged transgenic embryonic zebrafish in vivo using a light-sheet fluorescence microscopy system with 4D cardiac motion synchronization. Our method permits the derivation of a transformation matrix to quantify the time-dependent 3D displacement of segmental myocardial mass centroids. Through treatment with doxorubicin, and by chemically and genetically manipulating the myocardial injury–activated Notch signaling pathway, we used DIAMOND to demonstrate that basal ventricular segments adjacent to the atrioventricular canal display the highest 3D displacement and are also the most susceptible to doxorubicin-induced injury. Thus, DIAMOND provides biomechanical insights into in vivo segmental cardiac function scalable to high-throughput research applications.
Polo-Like Kinase 1 Is Essential for Early Embryonic Development and Tumor Suppression
Lu, Lin-Yu, Wood, Jamie L., Minter‐Dykhouse, Katherine, Saunders, Thomas L. , Yu, Xiaochun , Lu, Lin‐Yu , Ye, Lin , Chen, Junjie

Mayo Clinic

Molecular and Cellular Biology | September 16, 2008 | Volume: 28 | Issue: 22 | Pages: 6870-6876

10.1128/mcb.00392-08 | PMID 18794363 Get It

Generation and Characterization of Novel Monoclonal Antibodies Against Human Aurora-A
Wu, Liming , Beito, Tom, Chen, Junjie

Mayo Clinic

Hybridoma | August 17, 2008 | Volume: 27 | Issue: 4 | Pages: 313-318

10.1089/hyb.2008.0016 | PMID 18707550 Get It

MDC1 regulates intra-S-phase checkpoint by targeting NBS1 to DNA double-strand breaks
Wu, Liming , Luo, Kuntian, Lou, Zhenkun , Chen, Junjie

Mayo Clinic

Proceedings of the National Academy of Sciences | August 4, 2008 | Volume: 105 | Issue: 32 | Pages: 11200-11205

10.1073/pnas.0802885105 | PMID 18678890 Get It

The product of the Nijmegen breakage syndrome gene (NBS1) plays crucial roles in DNA damage response through its association with many proteins, including MRE11 and RAD50. However, it remains to be determined exactly how NBS1 accumulates at or near DNA double-strand breaks. Here we report that MDC1 directly binds to NBS1 and targets NBS1 to the sites of DNA damage. The MDC1–NBS1 interaction occurs through a specific region (residues 200–420) of MDC1, which contains multiple consensus casein kinase 2 (CK2) phosphorylation sites. In addition, this interaction requires both the forkhead-associated (FHA) and tandem BRCA1 C-terminal (BRCT) domains of NBS1. Disruption of the MDC1–NBS1 interaction results in failure of NBS1 accumulation at DNA double-strand breaks and impairment of intra-S checkpoint activation. These studies provide important mechanistic insights as to how MDC1 regulates NBS1 and the intra-S-phase checkpoint in response to DNA damage.
Distinct versus overlapping functions of MDC1 and 53BP1 in DNA damage response and tumorigenesis
Minter‐Dykhouse, Katherine, Ward, Irene M., Huen, Michael S.Y. , Chen, Junjie , Lou, Zhenkun

Mayo Clinic

The Journal of Cell Biology | May 27, 2008 | Volume: 181 | Issue: 5 | Pages: 727-735

10.1083/jcb.200801083 | PMID 18504301 Get It

The importance of the DNA damage response (DDR) pathway in development, genomic stability, and tumor suppression is well recognized. Although 53BP1 and MDC1 have been recently identified as critical upstream mediators in the cellular response to DNA double-strand breaks, their relative hierarchy in the ataxia telangiectasia mutated (ATM) signaling cascade remains controversial. To investigate the divergent and potentially overlapping functions of MDC1 and 53BP1 in the ATM response pathway, we generated mice deficient for both genes. Unexpectedly, the loss of both MDC1 and 53BP1 neither significantly increases the severity of defects in DDR nor increases tumor incidence compared with the loss of MDC1 alone. We additionally show that MDC1 regulates 53BP1 foci formation and phosphorylation in response to DNA damage. These results suggest that MDC1 functions as an upstream regulator of 53BP1 in the DDR pathway and in tumor suppression.